Multidisciplinary Clinical Pharmacology in Complex Pharmacotherapy: Drug-Related Errors, Pharmacovigilance, and Evidence-Based Strategies for Medication Safety—A Systematic Review and Meta-Analysis
Authors:
- Nodar SulashviliNodar Sulashvili
- Margarita BeglaryanMBMargarita Beglaryan
- Nato AlavidzeNANato Alavidze
- Nana GorgaslidzeNGNana Gorgaslidze
- Diego Rada Fernandez de JaureguiDJDiego Rada Fernandez de Jauregui
- Naira ChichoyanNCNaira Chichoyan
- Maka JavakhiaMJMaka Javakhia
- Nino AbuladzeNANino Abuladze
- Ketevani GabuniaKGKetevani Gabunia
- Vira KravchenkoVKVira Kravchenko
- Olga ShapovalOSOlga Shapoval
Open Access
- 16 September 2026
- journal article
- review article
- Published by Public Health Institute of Georgia in Georgian Medical Journal
- Vol. 1 (4)
Abstract
Background: Complex pharmacotherapy has become a defining feature of modern clinical care, particularly in older adults, patients with multimorbidity, and those moving across care settings. As the number of prescribed medicines increases, so does the risk of drug-related errors, adverse drug reactions, inappropriate prescribing, and preventable medication-related harm. Clinical pharmacology offers a practical bridge between therapeutic complexity and safer prescribing, monitoring, and deprescribing. This systematic review and meta-analysis synthesizes evidence on the burden, determinants, and prevention of medication-related harm in complex pharmacotherapy. Methods: We conducted a systematic review and meta-analysis in accordance with PRISMA guidelines. Electronic databases including PubMed/MEDLINE, Embase, Scopus, Web of Science, and Cochrane Library were searched from inception to 2024. Eligible studies included observational studies reporting medication-related errors, adverse drug events, or drug-related hospital use in adults exposed to polypharmacy (≥5 concurrent medicines) or complex pharmacotherapy, alongside interventional studies evaluating medication safety strategies. Risk of bias was assessed using design-specific tools (Newcastle-Ottawa Scale, Cochrane ROB, ROBINS-I), and evidence certainty was graded using GRADE. Random-effects meta-analyses were performed where clinical and methodological homogeneity permitted. Results: From 2,847 initially identified records, 87 studies met inclusion criteria, with 42 contributing to quantitative synthesis. The pooled prevalence of preventable medication harm was 3.0% (95% CI 2.4–3.6%), with higher rates in intensive care (5.2%) and older adults (4.1%). Polypharmacy prevalence among older adults was 41.4%, with adverse drug reaction frequencies increasing from 11.5% (2–5 medications) to 16.9% (≥5 medications). Potentially inappropriate prescribing affected 34.2% of older adults and was significantly associated with adverse drug events (OR 1.26, 95% CI 1.11–1.44). Medication discrepancies occurred in 53.7% of patients during care transitions, with discharge discrepancies doubling 30-day readmission risk (RR 2.12, 95% CI 1.76–2.55). Pharmacist-led reconciliation reduced adverse drug event-related hospital revisits by 67% (RR 0.33, 95% CI 0.20–0.53). Multicomponent interventions demonstrated the largest effects (medication errors RR 0.28, 95% CI 0.18–0.44), with favorable cost-effectiveness profiles ($2,500–$5,000 per QALY gained). Conclusion: Medication safety in complex pharmacotherapy is best approached as a systems problem rather than a single-prescriber issue. Evidence supports clinically grounded, pharmacology-informed strategies centered on structured medication review, safer transitions of care, stronger pharmacovigilance, and multidisciplinary stewardship. These findings are directly relevant to health systems in Georgia and the wider region, where aging populations, multimorbidity, and fragmented care increasingly converge. Keywords: Complex Pharmacotherapy; Medication Safety; Polypharmacy; Pharmacovigilance; Drug-Related Errors; Systematic Review.Keywords
This publication has 66 references indexed in Scilit:
- Strengthening Pharmacovigilance Reporting for Withdrawal Reactions to Support DeprescribingClinical Pharmacology & Therapeutics, 2026
- Recommendations to Enable Broader Use of Real‐World Evidence to Inform Decision‐Making Throughout Pharmacovigilance Signal ManagementPharmacoepidemiology and Drug Safety, 2025
- Review of Studies Evaluating Effectiveness of Risk Minimization Measures Assessed by the European Medicines Agency Between 2016 and 2021Clinical Pharmacology & Therapeutics, 2023
- Prevalence of Use of Potentially Inappropriate Medications Among Older Adults WorldwideJAMA Network Open, 2023
- The MedSafer Study—Electronic Decision Support for Deprescribing in Hospitalized Older AdultsJAMA Internal Medicine, 2022
- What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?Pharmacoepidemiology and Drug Safety, 2020
- Postmarket Safety Communication for Protection of Public Health: A Comparison of Regulatory Policy in Australia, Canada, the European Union, and the United StatesClinical Pharmacology & Therapeutics, 2020
- Interventions to improve the appropriate use of polypharmacy for older peopleCochrane Database of Systematic Reviews, 2018
- Perifollicular Xanthomatosis as the Hallmark of Axillary Fox-Fordyce DiseaseArchives of Dermatology, 2008
- Adverse Drug Events in Hospitalized PatientsExcess Length of Stay, Extra Costs, and Attributable MortalityJAMA, 1997